Virtus LifeSci Biotech Clinical Trials ETF
BBC NYSE Arca
The Fund invests in clinical trials stage biotechnology companies. Clinical Trials stage companies are typically younger, smaller companies which do not have a drug approved, but instead focus on testing their experimental drug candidates in human clinical trials.
Hover to inspectDrag to measure a move← → to step through days
- Fund size
- 31.9M as of Feb 2020
- Expense ratio
- 0.79% per year
- Dividend yield
- 0.00% Yearly
- Volatility · 1Y
- 37.2% High Risk
- Beta
- 1.18 vs the market
- 52-week range
- 28.7656.03
How BBC has paid off
Price return over every period, and total return with dividends reinvested, set against price alone.
Return by period
Price · to Oct 12Total return vs price return
Price onlyOver 1 year, BBC returned +49.7% with dividends reinvested — dividends added 0.0 pts to the price move.
How bumpy is the ride?
Return only means something next to the risk taken to earn it. Volatility, drawdowns and market sensitivity over 1 year.
Volatility
Annualized · 1YA typical year sees the price swing about ±37% around its trend.
Drawdown from peak
How far below its previous high the price has been Deepest fall −23.1% on Oct 12, 2026 — 54 days after the previous high
More than 5% below a high 49% of the time.
Market sensitivity
BetaA beta of 1.18 means BBC has moved more than the market.
Trend & momentum
Where the price sits against its moving averages, and how stretched the recent move is.
Price vs moving averages
Uptrend- 12-day average44.70 −3.7%
- 26-day average46.70 −7.8%
- 50-day average48.19 −10.7%
- 200-day average44.42 −3.1%
The price is above 0 of 4 averages. The 50-day average is above the 200-day, a sign of a rising longer-term trend.
Relative strength (RSI)
OversoldRSI compares recent gains with recent losses on a 0–100 scale. Above 70 a move is often considered stretched, below 30 washed out.
Technical indicators describe past prices. They are not a forecast.
Inside the fund
Health Care · Biotech — tracking the LifeSci Biotechnology Clinical Trials Index.
- Assets under management31.9MUSD
- Expense ratio0.79%per year
- Holdings99
- Risk score7.2High
Launched December 2014. Fund data as of Feb 27, 2020.
Where BBC shows up
Curated themes and indices that hold BBC. Open one to see it in context, or test the whole theme in a portfolio.
About Virtus LifeSci Biotech Clinical Trials ETF
The Fund invests in clinical trials stage biotechnology companies. Clinical Trials stage companies are typically younger, smaller companies which do not have a drug approved, but instead focus on testing their experimental drug candidates in human clinical trials.
- Featured in 1 curated theme
- 99 holdings
- Ticker
- BBC
- Exchange
- NYSE Arca
- ISIN
- US26923G3011
- CUSIP
- 26923G301
- Currency
- U.S. Dollar (USD)
- Country
- USA
- Sector
- Health Care
- Industry
- Biotech
- Benchmark
- LifeSci Biotechnology Clinical Trials Index
All key statistics
Details
Shareas of Oct 12, 2026
Dataas of Feb 27, 2020
Put BBC to the test
See how it would change the return and the risk of a portfolio, with virtual money, before a single real dollar moves.
Data for information only, not investment advice. Past performance does not guarantee future results.